Shopping Cart
- Remove All
- Your shopping cart is currently empty
MS-444 (BE-34776) is a smooth muscle myosin light chain kinase (MLCK) and HuR inhibitor with antitumor activity for triple-negative breast and colorectal cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $624 | In Stock | |
2 mg | $865 | In Stock | |
25 mg | $1,820 | 8-10 weeks | |
50 mg | $2,380 | 8-10 weeks | |
100 mg | $3,100 | 8-10 weeks |
Description | MS-444 (BE-34776) is a smooth muscle myosin light chain kinase (MLCK) and HuR inhibitor with antitumor activity for triple-negative breast and colorectal cancer. |
Targets&IC50 | RIE-1 cells:40.70 μM, YAMC cells:28.16 μM, RKO cells:5.60 μM, SW480 cells:10.98 μM, HT-29 cells:14.21 μM, HCA-7 cells:12.84 μM, HCT116 cells:10.98 μM |
In vitro | MS-444 is a small molecule RNA-binding protein HuR (ELAVL1) inhibitor. Colorectal cancer (CRC) cells that show HuR overexpression are treated with MS-444 (1-100 μM) for 48 hr (HCT116 IC50=10.98 μM, HCA-7 IC50=12.84 μM, RKO IC50=5.60 μM, HT-29 IC50=14.21 μM, and SW480 IC50=10.98 μM). Contrasting effects are observed using non-transformed small intestinal (RIE-1 IC50=40.70 μM) and colonic epithelial cells (YAMC IC50=28.16 μM). [1] |
In vivo | Mice bearing HCT116 cell xenografts receive intraperitoneal injections of MS-444 (25 mg/kg) or vehicle every 48 hr to test the effects of MS-444 on CRC cell growth in vivo. Anti-tumor effects of MS-444 are observed with an approximately 1.7-fold reduction in tumor size. Mice treated with MS-444 shows a marked 2- to 3-fold reduction in microvessel density (MVD), showing the anti-angiogenic potential of MS-444. [1] |
Alias | MS444, BE-34776, BE34776 |
Molecular Weight | 230.22 |
Formula | C13H10O4 |
Cas No. | 150045-18-4 |
Smiles | O=C1C=2C(O)=CC=C(O)C2CC3=COC(=C13)C |
Relative Density. | 1.452g/cm3 |
Storage | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (173.75 mM.), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.